Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV

NCT06114810 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

880

Enrollment

OTHER

Sponsor class

Conditions

Polio

Interventions

BIOLOGICAL: polio vaccines: nOPV2, bOPV, IPV

Sponsor

International Centre for Diarrhoeal Disease Research, Bangladesh

Collaborators

[object Object]
[object Object]